C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2001
11/30/2001	CA2349057A1 Enzymatic oxidations
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090084A1 Benzodiazepine derivatives as app modulators
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090080A1 Method of combating undesired plant growth on cereals
11/29/2001	WO2001090077A1 Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
11/29/2001	WO2001090071A2 Substituted iminoazines used as herbicides
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001040198A3 Macrocyclic hydroxamic acid derivatives and their use as antimicrobial agents
11/29/2001	WO2001034576A3 Use of pyrimidinone derivatives for controlling undesired microorganisms
11/29/2001	WO2001030780A3 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
11/29/2001	WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001	WO2000039114A3 Substituted oximes and hydrazones as neurokinin antagonists
11/29/2001	US20010047038 Treating the patient suffering for herpes viruses, and cytomegalovirus with an effective amount of sulfur or sulfoxide or sulfonyl containing heteroaromatic compounds
11/29/2001	US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001	US20010047013 Process for the preparation of arylamines
11/29/2001	US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/29/2001	US20010046994 Hexahydrotriazine compounds and insecticides
11/29/2001	US20010046989 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
11/29/2001	US20010046985 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
11/29/2001	US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors
11/29/2001	DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease
11/29/2001	DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2409142A1 Substituted iminoazines
11/29/2001	CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408604A1 Method of combating undesired plant growth on cereals
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158358A2 Imaging element containing a blocked photographically useful compound
11/28/2001	EP1157989A1 Fluorides of 4-substituted piperidine derivatives
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157019A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
11/28/2001	EP1157011A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
11/28/2001	EP1157008A1 Quinoline derivatives as tyrosine kinase inhibitors
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157005A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
11/28/2001	EP1156807A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP0830344B1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
11/28/2001	EP0690712B1 Taxanes having a pyridyl substituted side-chain
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	CN1324354A Vitreous form of know bradykinin antagonist
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324348A TAN-1057 derivatives
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1323796A Novel cyclobutaneindazol carboxylamine compound, their prepn. method and pharmaceutical compositions
11/27/2001	US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001	US6323227 Prodrugs
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001	US6323217 Cardiovascular disorders
11/27/2001	US6323215 Treat and prevent disorders characterized by neuronal damage such as parkinson's disease, alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and bell's palsy.
11/27/2001	US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001	US6323211 Alpha.-adrenergic receptor antagonist and at least one compound that elevates endogenous nitric oxide or endothelium-derived relaxing factor in vivo
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6322770 Indazole vitronectin receptor antagonist pharmaceuticals
11/27/2001	CA2073446C Pyridylsulfonylureas as herbicides and plant growth regulators, processes for their preparation and their use
11/27/2001	CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001	WO2001087888A1 Pyrazolopyrimidinone derivatives, process for their preparation and their use
11/22/2001	WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087881A1 Piperidyindoles as serotonin receptor ligands
11/22/2001	WO2001087874A1 Process for producing crystal
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087851A1 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087834A1 Melanin-concentrating hormone antagonist
11/22/2001	WO2001087831A2 Novel amorphous form of omeprazole salts
11/22/2001	WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001	WO2001087376A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/22/2001	WO2001087374A1 Delivery systems for treatment of vascular disease
11/22/2001	WO2001087373A1 Delivery devices for treatment of vascular disease
11/22/2001	WO2001087342A2 Delivery devices for treatment of vascular disease
11/22/2001	WO2001087299A1 Aralkyl ester soft drugs
11/22/2001	WO2001087288A2 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/22/2001	WO2001087287A2 Use of pyrazole derivatives for treating infertility

1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 1080